Your session is about to expire
← Back to Search
Artificial Intelligence
AI-Based Fall Detection for Alzheimer's Disease
N/A
Waitlist Available
Research Sponsored by SafelyYou
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up data will be collected during year 1 and assessed at the end of year 1.
Awards & highlights
Study Summary
This trial will study if the SafelyYou system can detect falls and provide better support for people with dementia who live in long-term care facilities.
Who is the study for?
This trial is for adults with Alzheimer's Disease who live in a participating skilled nursing facility or continuing care retirement community. It aims to help those at risk of falls due to dementia. People under the age of 18 cannot participate.Check my eligibility
What is being tested?
The SafelyYou Fall Prevention System, which uses AI-enabled cameras to detect and alert staff about fall events in real-time, is being tested for its effectiveness in preventing injuries from unwitnessed falls among dementia patients.See study design
What are the potential side effects?
Since this trial involves a monitoring system rather than medication, traditional side effects are not expected. However, there may be concerns related to privacy due to video surveillance.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ data will be collected during year 1 and assessed at the end of year 1.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~data will be collected during year 1 and assessed at the end of year 1.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Enrollment rate
Fall rate due to gait change detection
Fall rate due to sit to stand transition detection
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
AI-enabled camera fall detection with Human-in-the-Loop (HIP) review
Group II: ControlActive Control1 Intervention
No camera detection
Find a Location
Who is running the clinical trial?
SafelyYouLead Sponsor
1 Previous Clinical Trials
300 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,667 Previous Clinical Trials
28,004,434 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still availability for people to enroll in this research?
"Per the information available on clinicaltrials.gov, this research project is no longer enrolment participants. Initially posted in October of 2023 and last altered May 5th 2022, it appears that recruitment for this trial has been concluded; however there are an additional 557 studies recruiting patients currently."
Answered by AI
Who else is applying?
What state do they live in?
California
How old are they?
65+
What site did they apply to?
SafelyYou
What portion of applicants met pre-screening criteria?
Did not meet criteria
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger